Navigation Links
Oxford Finance Completes $271.4 Million Securitization Transaction
Date:5/4/2012

ALEXANDRIA, Va., May 4, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a term loan securitization transaction completed on April 26, 2012. The $271.4 million securitization consisted of class A notes rated A2 (sf) by Moody's Investors Service. Guggenheim Securities, LLC was the arranger of the notes, and Oxford is the sponsor, originator and servicer for this transaction.

"This transaction is Oxford's second term securitization within the past year, and we appreciate the strong interest from an expanded base of investors," said J. Alden Philbrick, president and chief executive officer of Oxford Finance.  "We are very pleased that the financial community continues to recognize the quality of our portfolio, which is underscored by the continued A2 (sf) rating by Moody's."

About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated nearly $2 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.


'/>"/>
SOURCE Oxford Finance LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies
2. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
3. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
4. Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B
5. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
6. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
7. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
8. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
9. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
10. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
11. Oxford BioTherapeutics Appoints Michael Moore as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Calif. , April 20, 2015  Ardelyx, ... company focused on cardio-renal, gastrointestinal and metabolic diseases, ... MRCP, has joined the Company,s Board of Directors. ... and board level experience, having built and led ... development, regulatory approval and into healthcare systems globally. ...
(Date:4/20/2015)... INDIANAPOLIS , April 20, 2015  Eli Lilly ... stage data from several targeted cancer therapies, reflecting Lilly,s ... Research (AACR) Annual Meeting 2015, held April 18-22 in ... "Bringing Cancer Discoveries to Patients" is the theme of ... through Lilly,s commitment to broadening its portfolio of therapies ...
(Date:4/20/2015)... - Development of a Novel ... VOLVOX Platform - To be Presented on Tuesday, Apr ... Assembly of Antibody-drug Conjugates Using an anti-HER2 Monoclonal Antibody ... Apr 19, 1:00 PM EST Invictus Oncology ... announced that the company,s novel computational platform technology (VOLVOX) ...
(Date:4/20/2015)... BEIJING, April 20, 2015 Sinovac Biotech Ltd. ... China, today announced its unaudited financial results for the ... Fourth Quarter 2014 Financial Highlights(Compared to the ... $20.3 million, a decrease of 11.4% from $22.9 million ... the stockpiling of H5N1 pandemic influenza vaccine of $0.1 ...
Breaking Biology Technology:Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18
... ISELIN, N.J., Sept. 12 SyntheMed, Inc. ... will host a symposium,entitled "Post-Operative Adhesions in ... next week,s European Association for,Cardio- Thoracic Surgery ... be chaired by Professor Stephen Westaby of ...
... Sept. 12 Two new white papers ... free download from,Microtest ( http://www.microtestlabs.com ). The ... device manufacturers and one which is specialized,for ... associated with sterility testing and reviews different ...
... 12 Prolog Ventures, a venture capital,firm specializing ... has joined the firm as its fourth partner. ... early-stage investing, venture fund,management, and technology commercialization. ... director at Mason,Wells in Milwaukee, WI, where he ...
Cached Biology Technology:SyntheMed to Host Symposium on Adhesions in Cardiac Surgery 2Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ... Biometrics - Global Strategic Business Report" report to their offering. ... Voice Biometrics in US$ Thousands by the following Segments: Face Biometrics, ... US, Canada , Japan , ... Middle East & Africa , ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... October 17, 2011 The Peggy Lillis Memorial ... and Senior Vice President of Optimer Pharmaceuticals, Inc. and ... Tufts University, with an achievement award to recognize his ... new treatments for Clostridium difficile infection (CDI) ...
... -- October 17, 2011-- In a paper published today in ... Mary R. Loeken, PhD, has identified the enzyme AMP kinase (AMPK) ... of neural tube defects such as spina bifida and some heart ... if women with diabetes -- either type 1 or type 2 ...
... occurs naturally in bacteria as Ralstonia eutropha ... biodegradable and is not dependent on fossil resources, this ... replace petroleum-based plastics. New research reported in BioMed Central,s ... an alternative method of producing PHB in microalgae. ...
Cached Biology News:Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection 2Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection 3Joslin study finds clue to birth defects in babies of mothers with diabetes 2
... is portable, easy-to-use and makes identifying your samples ... Easy to use Labels withstand extreme ... sizes Time/Date stamp Laboratory ... Serialization feature makes you more efficient ...
Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
...
...
Biology Products: